{"id":484,"date":"2016-02-11T08:28:45","date_gmt":"2016-02-11T14:28:45","guid":{"rendered":"http:\/\/www.masstortlawyerblog.com\/?p=484"},"modified":"2018-04-23T11:48:52","modified_gmt":"2018-04-23T16:48:52","slug":"seventh-circuit-upholds-dismissal-generic-drug-lawsuit-preemption-grounds","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/seventh-circuit-upholds-dismissal-generic-drug-lawsuit-preemption-grounds\/","title":{"rendered":"Seventh Circuit Upholds Dismissal of Generic Drug Lawsuit on Preemption Grounds"},"content":{"rendered":"

This month, a panel of federal appellate judges upheld the dismissal of a plaintiff’s action against\u00a0the manufacturer of the\u00a0generic drug allopurinol<\/a>,\u00a0based on preemption. In\u00a0Houston v. United States<\/em>, the plaintiff alleged that in 2011 he was diagnosed with gout, which is a type of arthritis, and prescribed allopurinol. This drug is a generic version of the brand name drug Zyloprim. Roughly 30 days later, the plaintiff indicated that he developed a rash on his face and pain in his eye. He was eventually diagnosed with Stevens-Johnson syndrome (SJS), a life-threatening skin condition, which his treating physicians attributed to a reaction to the allopurinol.<\/p>\n

The plaintiff initiated an action in 2014 against the drug maker, Qualitest, the medical facility, and his health care provider, alleging that the drug maker failed to provide an adequate warning about the risk of developing SJS after taking the drug. The plaintiff also alleged a design defect claim.\u00a0The health care facility and physicians were funded by the federal government, so the United States removed the action to federal court. All three defendants then filed a motion to dismiss, which the district court granted.<\/p>\n

Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

This month, a panel of federal appellate judges upheld the dismissal of a plaintiff’s action against\u00a0the manufacturer of the\u00a0generic drug allopurinol,\u00a0based on preemption. In\u00a0Houston v. United States, the plaintiff alleged that in 2011 he was diagnosed with gout, which is a type of arthritis, and prescribed allopurinol. This drug is a generic version of the […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-484","post","type-post","status-publish","format-standard","hentry","category-pharmaceuticals"],"yoast_head":"\nSeventh Circuit Upholds Dismissal of Generic Drug Lawsuit on Preemption Grounds — Illinois Injury and Mass Tort Lawyer Blog — February 11, 2016<\/title>\n<meta name=\"description\" content=\"This month, a panel of federal appellate judges upheld the dismissal of a plaintiff's action against\u00a0the manufacturer of the\u00a0generic drug — February 11, 2016\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/seventh-circuit-upholds-dismissal-generic-drug-lawsuit-preemption-grounds\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Seventh Circuit Upholds Dismissal of Generic Drug Lawsuit on Preemption Grounds — Illinois Injury and Mass Tort Lawyer Blog — February 11, 2016\" \/>\n<meta name=\"twitter:description\" content=\"This month, a panel of federal appellate judges upheld the dismissal of a plaintiff's action against\u00a0the manufacturer of the\u00a0generic drug — February 11, 2016\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Seventh Circuit Upholds Dismissal of Generic Drug Lawsuit on Preemption Grounds — Illinois Injury and Mass Tort Lawyer Blog — February 11, 2016","description":"This month, a panel of federal appellate judges upheld the dismissal of a plaintiff's action against\u00a0the manufacturer of the\u00a0generic drug — February 11, 2016","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/seventh-circuit-upholds-dismissal-generic-drug-lawsuit-preemption-grounds\/","twitter_card":"summary_large_image","twitter_title":"Seventh Circuit Upholds Dismissal of Generic Drug Lawsuit on Preemption Grounds — Illinois Injury and Mass Tort Lawyer Blog — February 11, 2016","twitter_description":"This month, a panel of federal appellate judges upheld the dismissal of a plaintiff's action against\u00a0the manufacturer of the\u00a0generic drug — February 11, 2016","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.molllawgroup.com\/blog\/seventh-circuit-upholds-dismissal-generic-drug-lawsuit-preemption-grounds\/#article","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/seventh-circuit-upholds-dismissal-generic-drug-lawsuit-preemption-grounds\/"},"author":{"name":"Moll Law Group","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"headline":"Seventh Circuit Upholds Dismissal of Generic Drug Lawsuit on Preemption Grounds","datePublished":"2016-02-11T14:28:45+00:00","dateModified":"2018-04-23T16:48:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/seventh-circuit-upholds-dismissal-generic-drug-lawsuit-preemption-grounds\/"},"wordCount":583,"articleSection":["Pharmaceuticals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/seventh-circuit-upholds-dismissal-generic-drug-lawsuit-preemption-grounds\/","url":"https:\/\/www.molllawgroup.com\/blog\/seventh-circuit-upholds-dismissal-generic-drug-lawsuit-preemption-grounds\/","name":"Seventh Circuit Upholds Dismissal of Generic Drug Lawsuit on Preemption Grounds — Illinois Injury and Mass Tort Lawyer Blog — February 11, 2016","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"datePublished":"2016-02-11T14:28:45+00:00","dateModified":"2018-04-23T16:48:52+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"This month, a panel of federal appellate judges upheld the dismissal of a plaintiff's action against\u00a0the manufacturer of the\u00a0generic drug — February 11, 2016","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/seventh-circuit-upholds-dismissal-generic-drug-lawsuit-preemption-grounds\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/seventh-circuit-upholds-dismissal-generic-drug-lawsuit-preemption-grounds\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/seventh-circuit-upholds-dismissal-generic-drug-lawsuit-preemption-grounds\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Seventh Circuit Upholds Dismissal of Generic Drug Lawsuit on Preemption Grounds"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/484","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=484"}],"version-history":[{"count":3,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/484\/revisions"}],"predecessor-version":[{"id":2235,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/484\/revisions\/2235"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=484"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=484"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=484"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}